Free Trial
NASDAQ:CALA

Calithera Biosciences (CALA) Stock Price, News & Analysis

Calithera Biosciences logo
$0.0001 0.00 (-90.00%)
As of 09:30 AM Eastern

About Calithera Biosciences Stock (NASDAQ:CALA)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.00
$0.05
Volume
2,500 shs
Average Volume
14,303 shs
Market Capitalization
$487.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Calithera Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

CALA MarketRank™: 

Calithera Biosciences scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Calithera Biosciences.

    • Percentage of Shares Shorted

      0.43% of the float of Calithera Biosciences has been sold short.
    • Short Interest Ratio / Days to Cover

      Calithera Biosciences has a short interest ratio ("days to cover") of 48.5, which indicates bearish sentiment.
    • Change versus previous month

    • Dividend Yield

      Calithera Biosciences does not currently pay a dividend.

    • Dividend Growth

      Calithera Biosciences does not have a long track record of dividend growth.

    • Percentage of Shares Shorted

      0.43% of the float of Calithera Biosciences has been sold short.
    • Short Interest Ratio / Days to Cover

      Calithera Biosciences has a short interest ratio ("days to cover") of 48.5, which indicates bearish sentiment.
    • Change versus previous month

    • Search Interest

      1 people have searched for CALA on MarketBeat in the last 30 days.
    Receive CALA Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

    CALA Stock News Headlines

    Calithera Biosciences Inc (CALA)
    The mainstream media is wrong about AI — again
    The mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And the media jumped to hasty conclusions. But as usual, there's one huge thing they missed.
    Arcus Biosciences Inc (RCUS)
    Christina Cala
    CALA - Calithera Biosciences, Inc.
    See More Headlines

    CALA Stock Analysis - Frequently Asked Questions

    Calithera Biosciences' stock was trading at $0.0001 at the beginning of the year. Since then, CALA stock has increased by 0.0% and is now trading at $0.0001.
    View the best growth stocks for 2025 here
    .

    Calithera Biosciences, Inc. (NASDAQ:CALA) released its quarterly earnings data on Monday, November, 8th. The biotechnology company reported ($3.00) earnings per share for the quarter, beating the consensus estimate of ($4.60) by $1.60. The biotechnology company had revenue of $6.75 million for the quarter.

    Calithera Biosciences shares reverse split on the morning of Wednesday, June 15th 2022.The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

    Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX) and First Solar (FSLR).

    Company Calendar

    Last Earnings
    11/08/2021
    Today
    7/01/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:CALA
    Fax
    N/A
    Employees
    60
    Year Founded
    2010

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    N/A
    Price / Cash Flow
    N/A
    Price / Book
    N/A

    Miscellaneous

    Free Float
    4,550,000
    Market Cap
    $487.00
    Optionable
    Not Optionable
    Beta
    -2.56

    Social Links

    These 7 Stocks Will Be Magnificent in 2025 Cover

    Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

    Get This Free Report

    This page (NASDAQ:CALA) was last updated on 7/1/2025 by MarketBeat.com Staff
    From Our Partners